AMH Test in Australia

What an AMH test is

Anti-Müllerian hormone is produced by the granulosa cells of small pre-antral and early antral follicles, so its concentration in blood tracks how many of those small follicles remain.

Every ovary begins with a finite pool of follicles that declines steadily with age. Because AMH is secreted by the earliest recruitable follicles rather than by the single follicle that a given cycle happens to select, its level stays comparatively stable across the menstrual cycle. That stability is exactly why it displaced day-3 FSH as the preferred first-line ovarian reserve marker in most Australian fertility practice — a sample can be taken on any day.

Australian pathology laboratories report AMH in picomoles per litre. Much of the international literature, and most United States sources, report nanograms per millilitre. The conversion is straightforward: ng/mL multiplied by 7.14 gives pmol/L. A woman told her AMH is '2.0' in an American forum and '14' by an Australian lab may be describing the same result.

It is important to be precise about what the number represents. AMH is a quantity signal. It says something about how many follicles remain; it says nothing about the chromosomal quality of the eggs within them, which is driven by age rather than by AMH.

Why AMH is measured

AMH is measured to estimate ovarian reserve before fertility treatment or egg freezing, to help predict response to ovarian stimulation, and as a supporting marker in the assessment of polycystic ovary syndrome.

In assisted reproduction, AMH is used chiefly to anticipate how the ovaries will respond to stimulation. A very low level suggests a poor response and fewer eggs collected; a very high level flags a risk of over-response and ovarian hyperstimulation syndrome, which changes how a specialist plans the cycle. This predictive use is well supported and is the test's strongest application.

Outside a fertility clinic, AMH is often requested by women who want information about their reproductive timeline. It can be genuinely useful context — particularly for those considering egg freezing or planning to delay pregnancy — but it is not a pregnancy predictor. Population studies have repeatedly found that among women without known infertility, AMH does not reliably predict the chance of conceiving naturally within a given timeframe.

AMH is also elevated in polycystic ovary syndrome because the characteristic feature of PCOS is a large number of small antral follicles. International PCOS guidance, led from Australia by the Monash Centre for Health Research and Implementation, has recognised AMH as a supporting marker in adults, used alongside clinical and biochemical assessment rather than as a standalone diagnostic.

What high AMH results can indicate

A high AMH usually reflects a large pool of small antral follicles, most commonly in polycystic ovary syndrome, and indicates a higher likelihood of strong ovarian response to stimulation.

In practical terms a high AMH is not, in itself, a problem — a larger follicle pool is generally an advantage in fertility treatment. What it changes is the way a specialist manages stimulation, because the same drug dose that produces a normal response in an average responder can produce an excessive one here, with a corresponding risk of ovarian hyperstimulation syndrome.

Because raised AMH is common in PCOS, an unexpectedly high result in someone with irregular cycles, acne or unwanted hair growth is a reasonable prompt to discuss a broader assessment with a GP — cycle history, androgens, glucose and insulin, and pelvic ultrasound where indicated. AMH alone does not diagnose PCOS.

Rarely, markedly elevated AMH is associated with granulosa cell tumours, which is one reason an unexpected extreme result should always be reviewed by a doctor rather than interpreted at home.

What low AMH results can indicate

A low AMH indicates a smaller remaining follicle pool for a woman's age, and predicts fewer eggs retrieved in a stimulated cycle — but it does not mean pregnancy is impossible.

AMH falls naturally with age, so 'low' has to be read against age. A level that would be unremarkable at 42 is a meaningful finding at 28, where it may warrant assessment for premature ovarian insufficiency along with FSH, oestradiol and, in some cases, genetic testing.

Low AMH can also follow ovarian surgery, chemotherapy or radiotherapy, and is seen in some autoimmune conditions. Hormonal contraception, particularly long-term combined pills, can suppress measured AMH modestly — typically by around 20% — which is worth mentioning to whoever interprets the result.

The most important framing point: a single low AMH result is not a verdict on your ability to conceive. Many women with low AMH conceive naturally. What a low result reliably signals is that if fertility treatment is being planned, time and specialist advice matter more, and a referral to a fertility specialist through your GP is the appropriate next step.

AMH reference ranges by age (Australian units)

Australian laboratories report AMH in pmol/L against age-banded reference intervals, because a level that is normal at 40 would be low at 25.

Different immunoassay platforms have historically produced different AMH values from the same sample, so results are best compared over time on the same assay at the same laboratory.

What affects your AMH result

Age is by far the largest influence on AMH, but hormonal contraception, the assay your laboratory runs, recent ovarian surgery, smoking and vitamin D status can all shift a result enough to change how it reads.

Before treating a number as your ovarian reserve, it is worth knowing what else moved it. Age accounts for most of the variation between two healthy women, and within one woman AMH declines gradually year on year rather than dropping off a cliff at a particular birthday. Everything below sits on top of that age trend.

The most common correctable confounder in Australian practice is hormonal contraception. Combined oral contraceptives, the vaginal ring and, to a lesser degree, progestogen-only methods suppress the recruitment of small follicles, and published studies consistently report measured AMH around 20% lower — occasionally more — during long-term use. The level generally recovers within a few months of stopping. If you are on the pill and the result matters for a decision about egg freezing, say so before the sample is taken, so whoever interprets it can factor it in or suggest repeating off contraception.

The second is the assay itself. AMH immunoassays from different manufacturers have historically produced different values from the same tube of blood, and Australian laboratories do not all run the same platform. This matters most when you are comparing a result to one taken two years ago at a different laboratory: the trend may be an artefact of the machine rather than a real change in your ovaries. Where you are tracking AMH over time, use the same laboratory each time.

Surgical and medical history matters too. Ovarian cystectomy — particularly for endometriomas — removes functioning ovarian tissue and can lower AMH measurably after the operation. Chemotherapy and pelvic radiotherapy have larger effects, which is why AMH is sometimes measured before oncology treatment in women of reproductive age. Current smoking is associated with modestly lower levels, and there is observational evidence linking very low vitamin D status with lower AMH, though whether correcting it changes the number is not settled.

Two things people expect to matter, and mostly do not: the day of your cycle and a recent meal. AMH varies only slightly across the menstrual cycle, and it does not require fasting.

Who should consider an AMH test

AMH testing is most informative for women planning fertility treatment or egg freezing, women with irregular cycles, and women who want an objective baseline before delaying pregnancy.

AMH is not recommended as a general population screening test in women who are not seeking fertility information, because a result in isolation frequently causes more anxiety than it resolves.

• Considering egg freezing, IVF or another assisted reproductive treatment.
• Trying to conceive without success, particularly after age 35.
• Irregular or absent periods, or a suspected diagnosis of PCOS.
• Previous ovarian surgery, chemotherapy or pelvic radiotherapy.
• A family history of early menopause or premature ovarian insufficiency.
• Wanting a documented baseline before deferring pregnancy for several years.

Which panel includes an AMH test

AMH is not part of FORM's four standard Australian panels, which are men's health panels — you order it as a single analyte, or add it to a panel you build yourself.

It is worth being straightforward about this rather than implying a bundle that does not exist. FORM's Australian panels — Essential, Pro, Elite Protocol and Ultra — are built around male hormonal, metabolic and organ-function markers, and none of them carry AMH. If ovarian reserve is the question you are trying to answer, the right route is either AMH on its own or a custom panel that pairs it with the markers a doctor is likely to want alongside it.

In practice, AMH is most useful with company. A GP or fertility specialist assessing ovarian reserve or irregular cycles will usually look at FSH and oestradiol on day 2–5 of the cycle, thyroid function, and often prolactin, because thyroid disease and raised prolactin are common, treatable causes of cycle disturbance that have nothing to do with egg numbers. Where PCOS is being considered, androgens and a metabolic screen including HbA1c usually come into the picture too.

• Build your own Australian panel — Add AMH to FSH, oestradiol, thyroid function and prolactin in a single blood draw, rather than ordering four separate tests.
• All Australian blood test panels — The four standard FORM Australia panels, from A$299 to A$1,499, with the full biomarker list for each.
• Thyroid function test — TSH, free T4 and free T3 — routinely checked alongside AMH when cycles are irregular.
• HbA1c test — The standard measure of average blood glucose, commonly ordered where PCOS is being assessed.
• Iron studies — Ferritin and transferrin saturation — the usual first stop when heavy periods and fatigue occur together.

How AMH testing works with FORM in Australia

You order directly, we issue an accredited-lab pathology request, and you receive a written interpretation to take to your GP or fertility specialist.

FORM provides testing and interpretation. We do not provide fertility treatment, prescribe medicines, or replace specialist care.

• Order online without a GP referral.
• Receive your pathology request form by email as a PDF.
• Attend a NATA-accredited (ISO 15189) collection centre on any day of your cycle.
• Receive a written, plain-English report explaining your result in context of your age.
• Discuss the result with your GP or a registered fertility specialist.